1. Current status and recent advances in preimplantation genetic testing for structural rearrangements
- Author
-
Cong-Jian Xu, Shuo Zhang, Caixia Lei, and Xiaoxi Sun
- Subjects
lcsh:Immunologic diseases. Allergy ,lcsh:RC648-665 ,medicine.diagnostic_test ,chromosome aneuploidy ,structural rearrangement ,Obstetrics and Gynecology ,Chromosome ,Aneuploidy ,Karyotype ,Chromosomal translocation ,Computational biology ,translocation karyotype ,Biology ,structural chromosomal rearrangement ,medicine.disease ,Genome ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,inversion karyotype ,Reproductive Medicine ,medicine ,DNA microarray ,Genetic diagnosis ,preimplantation genetic testing ,lcsh:RC581-607 ,Genetic testing - Abstract
Preimplantation genetic testing (PGT) is an early form of prenatal genetic diagnosis, which can identify the abnormal embryos cultured in vitro, allow only transfer of genetically normal embryos, and improve the pregnancy rate. In recent years, the rapid development of microarrays and next-generation sequencing (NGS) technologies has remarkably accelerated the clinical application of PGT. In particular, a variety of detection methods have emerged and achieved significant progress in PGT for structural rearrangements (PGT-SR). The detection-related abilities of these methods range from the detection of limited chromosome aneuploidy to comprehensive chromosome screening of the whole genome to differentiation of embryos with normal or balanced translocation/inversion karyotypes. In this study, we reviewed PGT-SR-related detection techniques to provide a better reference for clinical application and research. We have also discussed the potential development of novel techniques in the future.
- Published
- 2020